STM publisher Elsevier, Netherlands, has announced that the International Society for Cellular Therapy (ISCT) has selected Elsevier to publish Cytotherapy: The Journal of Cell Therapy, effective January 2013.
Cytotherapy claims to be a highly influential publication in the mainstream of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of these disciplines. It focuses especially on the practical translation of scientific developments in the laboratory into clinical practice.
Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, doctors, and regulatory experts involved in cell processing and therapy.
